China Shineway Pharmaceutical Group Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CSWYY research report →
Price Chart
About the company
As an investment holding company, China Shineway Pharmaceutical Group Limited primarily focuses on the research, development, production, and commercialization of traditional Chinese medicines across mainland China and Hong Kong. Its product portfolio encompasses contemporary Chinese medicines delivered as soft capsules, granules, and injectable solutions. Additionally, it provides specialized TCM Formula Granules, addressing a broad spectrum of medical conditions such as cardiovascular and cerebrovascular issues, viral infections, orthopedic complaints, pediatric ailments, gynecological disorders, and gastrointestinal problems.
- CEO
- Zhenjiang Li
- IPO
- 2012
- Employees
- 2,822
- HQ
- Shijiazhuang, HE, CN
Get TickerSpark's AI analysis on CSWYY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $36.35M
- P/E
- 5.52
- PEG
- 0.44
- P/S
- 1.66
- P/B
- 0.65
- EV/EBITDA
- -1.98
- Div Yield
- 7.54%
- Gross Margin
- 72.28%
- Op Margin
- 21.75%
- Net Margin
- 30.30%
- ROE
- 11.97%
- ROIC
- 5.93%
Latest fiscal year · YoY change
- Revenue
- $3.05B-19.3%
- Gross Profit
- $2.20B-22.2%
- Op Income
- $663.48M
- Net Income
- $924.07M+10.0%
- EPS
- $489.40+10.2%
- OCF Growth
- +21.7%
- FCF Growth
- +18.4%
- 52W High
- $22.54
- 52W Low
- $19.25
- 50D MA
- $19.25
- 200D MA
- $19.25
- Beta
- 0.72
- RSI (14)
- 100
- Avg Volume
- 1
No earnings-call transcripts are available for CSWYY yet.
- Free Float
- 33.7%
- Shares Outstanding
- 1.89M
- Float Shares
- 636.28K
Our CSWYY coverage
Recent articles, reports, and earnings notes.
No research on CSWYY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CSWYY report →